How Moderna execs are cashing in on COVID-19 vaccine stock speculation
By Tom Bergin and Robin RespautJuly 2 (Reuters) - Biotech firm Moderna Inc could reap tens of billions of dollars in sales and stock appreciation if it ...
By Tom Bergin and Robin RespautJuly 2 (Reuters) - Biotech firm Moderna Inc could reap tens of billions of dollars in sales and stock appreciation if it ...